104 related articles for article (PubMed ID: 25551305)
1. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia.
Pal M; Williams B
Pathology; 2015 Feb; 47(2):151-5. PubMed ID: 25551305
[TBL] [Abstract][Full Text] [Related]
2. Maternal red blood cell alloimmunisation in south western Uganda.
Natukunda B; Mugyenyi G; Brand A; Schonewille H
Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
[TBL] [Abstract][Full Text] [Related]
3. Clinical practices and outcomes of RhD immunoglobulin prophylaxis following large-volume fetomaternal haemorrhage in Queensland, Australia.
Tneh SY; Baidya S; Daly J
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):205-212. PubMed ID: 32789858
[TBL] [Abstract][Full Text] [Related]
4. Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme.
Foudoulaki-Paparizos L; Valsami S; Bournas N; Tsantes A; Grapsas P; Mantzios G; Travlou A; Politou M
Transfus Med; 2013 Aug; 23(4):254-9. PubMed ID: 23826966
[TBL] [Abstract][Full Text] [Related]
5. Female alloimmunization with antibodies known to cause hemolytic disease.
Geifman-Holtzman O; Wojtowycz M; Kosmas E; Artal R
Obstet Gynecol; 1997 Feb; 89(2):272-5. PubMed ID: 9015034
[TBL] [Abstract][Full Text] [Related]
6. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
7. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
8. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome.
Sankaralingam P; Jain A; Bagga R; Kumar P; Marwaha N
Transfus Apher Sci; 2016 Aug; 55(1):153-8. PubMed ID: 27324408
[TBL] [Abstract][Full Text] [Related]
9. [Possibility to identify fetomaternal haemorrhage].
Studnicková M; L'ubuský M; Ordeltová M; Procházka M
Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
[TBL] [Abstract][Full Text] [Related]
10. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
11. Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.
Minuk L; Clarke G; Lieberman L
Can Fam Physician; 2020 Jul; 66(7):491-498. PubMed ID: 32675093
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of red-cell antigens and antibodies in Malawi.
M'baya B; Mfune T; Mogombo E; Mphalalo A; Ndhlovu D; Knight RC
Transfus Med; 2010 Jun; 20(3):196-9. PubMed ID: 20015059
[TBL] [Abstract][Full Text] [Related]
13. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy.
Koelewijn JM; Vrijkotte TG; de Haas M; van der Schoot CE; Bonsel GJ
BJOG; 2009 Apr; 116(5):655-64. PubMed ID: 19210505
[TBL] [Abstract][Full Text] [Related]
15. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
Larsen R; Berkowicz A; Lousen T; Hedegaard M; Clausen FB; Krog GR; Dziegiel MH
Transfusion; 2008 Aug; 48(8):1707-12. PubMed ID: 18482192
[TBL] [Abstract][Full Text] [Related]
16. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of erythrocyte alloimmunization in pregnant women in olomouc region].
Holusková I; Lubušký M; Studničková M; Procházka M
Ceska Gynekol; 2013 Jan; 78(1):56-61. PubMed ID: 23607383
[TBL] [Abstract][Full Text] [Related]
18. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.
Debiec H; Nauta J; Coulet F; van der Burg M; Guigonis V; Schurmans T; de Heer E; Soubrier F; Janssen F; Ronco P
Lancet; 2004 Oct 2-8; 364(9441):1252-9. PubMed ID: 15464186
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.
Eipl K; Nakabiito C; Bwogi K; Motevalli M; Roots A; Blagg L; Jackson JB
Immunohematology; 2012; 28(4):115-7. PubMed ID: 23421539
[TBL] [Abstract][Full Text] [Related]
20. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
